Kailera Therapeutics, Inc. · NASDAQ:KLRA
Jiangsu Hengrui Pharmaceuticals Co., Ltd. converted 11,511,852 Kailera Therapeutics, Inc. shares (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (10% owner) converted 11,511,852 Kailera Therapeutics, Inc. shares, leaving 2,034,133 shares. Filed Apr 22, 2026 (Form 4).
- Converted
- 11,511,852 shares
- Holding after
- 2,034,133 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Conversion | 9,477,719 | 9,477,719 | Direct | |
| Apr 20, 2026 | Common Stock | Conversion | 2,034,133 | 2,034,133 | Direct |
Source
Related
- Kailera Therapeutics, Inc.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Kailera Therapeutics, Inc. shareholders
- Schedule 13G · Canada Pension Plan Investment Board · Aug 14, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026
- Schedule 13G · Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Aug 5, 2026
- Form 4 · Renaud Ronald C JR · Jun 11, 2026
- Schedule 13D · BCPE Perseus Investor, LP · Apr 23, 2026